Cargando…
Tumor Necrosis Factor Alpha Blocker-Induced Erythrodermic Sarcoidosis in with Juvenile Rheumatoid Arthritis: A Case Report and Review of the Literature
The development of cutaneous sarcoidosis as a paradoxical adverse event of tumor necrosis factor alpha (TNF-α) blockers has been reported in the literature; however, an erythrodermic form of cutaneous sarcoidosis during anti-TNF-α therapy has not yet been reported. Herein, we report the first case o...
Autores principales: | Park, Su-Kyung, Hwang, Pyung-Han, Yun, Seok-Kweon, Kim, Han-Uk, Park, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Dermatological Association; The Korean Society for Investigative Dermatology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318531/ https://www.ncbi.nlm.nih.gov/pubmed/28223750 http://dx.doi.org/10.5021/ad.2017.29.1.74 |
Ejemplares similares
-
Beta-Blocker-Induced Erythrodermic Psoriasis: A Case Report
por: Voloshyna, Diana, et al.
Publicado: (2022) -
High Body Mass Index is Associated with Shorter Retention of Tumor Necrosis Factor-Alpha Blocker Treatment in Rheumatoid Arthritis
por: Elalouf, Ofir, et al.
Publicado: (2021) -
Tumor necrosis factor-alpha polymorphism and susceptibility to juvenile idiopathic arthritis
por: Bayraktar, S, et al.
Publicado: (2008) -
The first reported case of erythrodermic sarcoidosis with systemic involvement during COVID-19 vaccination
por: Tchernev, Georgi, et al.
Publicado: (2023) -
Proteomics in Rheumatoid Arthritis Research
por: Park, Yune-Jung, et al.
Publicado: (2015)